Early, empirical broad-spectrum antibiotic treatment is the established practice for febrile neutropenia. Several beta-lactams are accepted for monotherapy. We asked whether patients' outcomes are influenced by the chosen beta-lactam.
- Anti-Bacterial Agents
- Enzyme Inhibitors
- Penicillanic Acid
- Quality Assurance, Health Care
- Randomized Controlled Trials as Topic
- Treatment Outcome